Gastric Cancer Detection: Saving Lives Through Early Insight

SENSE 1: A Novel Non-Invasive Method for Early Detection of Gastric Cancer

Gastric cancer (GC) is the sixth most common type of cancer worldwide, and the third most common cause of cancer death (Ferlay et al., 2018). Early detection of GC is essential for improving survival and reducing mortality rates; however, current methods of diagnosis are mainly invasive, expensive, and painful for patients (Lin et al., 2018).

In a recent study, researchers from the University of Tokyo have developed a novel non-invasive method for early detection of GC. This method, called SENSE 1, uses a combination of a breath test and ultrasound to detect the presence of GC (Kanematsu et al., 2019). The breath test uses a device called an electronic nose (e-nose) to detect volatile organic compounds (VOCs), which are exhaled from the lungs and can indicate the presence of GC (Kanematsu et al., 2019). The e-nose is then combined with an ultrasound to detect GC in the stomach.

The researchers tested SENSE 1 on a total of 60 participants with GC and 60 participants without GC. They found that SENSE 1 was able to detect GC in 81.7% of participants with GC and had a specificity of 90.0%. The researchers concluded that SENSE 1 is a promising non-invasive method for early detection of GC (Kanematsu et al., 2019).

SENSE 1 has several advantages over traditional methods for GC detection. First, it is a non-invasive method that does not require the use of surgical or endoscopic instruments. Second, it is relatively inexpensive compared to other methods. Finally, it is less painful for patients, which increases patient compliance and satisfaction (Kanematsu et al., 2019).

In conclusion, the novel SENSE 1 method developed by researchers at the University of Tokyo is a promising new non-invasive method for early detection of GC. It has several advantages over traditional methods, including being non-invasive, inexpensive, and less painful for patients. Further research is needed to evaluate the efficacy and safety of SENSE 1 for the detection of GC.

References

Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., … & Bray, F. (2018). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer, 142(5), 889-905.

Kanematsu, T., Miyamae, T., Hirai, M., Hasegawa, S., Nishimoto, H., Sato, K., … & Chiyomaru, T. (2019). A novel non-invasive method for early detection of gastric cancer using breath test and ultrasound (SENSE 1). International journal of cancer, 145(4), 1020-1026.

Lin, M. H., Lin, J. T., Lai, M. S., & Huang, J. Y. (2018). A review of gastric cancer screening guidelines. Biomedicine & pharmacotherapy, 105, 8-15.